Figure 1.
Kaplan–Meier analyses for OS (a) and remission duration (b) for patients with ETP-ALL and early T-ALL with a non-ETP immunophenotype. Patients were enrolled in the GMALL study trials GMALL 05/93, GMALL 06/99 and GMALL 07/03.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.